Autolus Therapeutics (AUTL) Cash from Investing Activities (2017 - 2025)
Autolus Therapeutics posted quarterly Cash from Investing Activities of $86.5 million for Q4 2025, up 122.56% year-on-year from $38.9 million in Q4 2024, and up 143.46% on a QoQ basis from $35.5 million in Q3 2025.
Autolus Therapeutics (AUTL) has 9 years of Cash from Investing Activities data on file, last reported at $86.5 million in Q4 2025.
- For the quarter ending Q4 2025, Cash from Investing Activities rose 122.56% year-over-year to $86.5 million; the trailing twelve-month figure through Dec 2025 stood at $158.5 million (up 140.16% YoY), and the FY2025 full-year result was $158.5 million, up 140.16% from the prior year.
- Cash from Investing Activities for Q4 2025 stood at $86.5 million, up from $35.5 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $95.9 million in Q2 2025 and bottomed at -$383.6 million in Q4 2024.
- The 5-year median for Cash from Investing Activities is -$1.5 million (2021), against an average of -$13.3 million.
- The widest annual swing landed in 2024, when Cash from Investing Activities plunged 25870.82%; it then surged 11504.88% in 2025.
- A 5-year view of Cash from Investing Activities shows it stood at -$1.6 million in 2021, then jumped by 60.06% to -$633000.0 in 2022, then plunged by 133.33% to -$1.5 million in 2023, then slumped by 25870.82% to -$383.6 million in 2024, then surged by 122.56% to $86.5 million in 2025.
- The last three Cash from Investing Activities figures came in at $86.5 million (Q4 2025), $35.5 million (Q3 2025), and $95.9 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -2.89 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 638.50 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | -431.90 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -428.90 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | -25.54 Mn |
| 10 | Autolus Therapeutics | - | - | -1.04 Mn | 86.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 86.54 Mn |
| Dec 31, 2025 | 86.54 Mn |
| Sep 30, 2025 | 35.55 Mn |
| Sep 30, 2025 | 35.55 Mn |
| Jun 30, 2025 | 95.92 Mn |
| Jun 30, 2025 | 95.92 Mn |
| Mar 31, 2025 | -59.55 Mn |
| Mar 31, 2025 | -59.55 Mn |
| Dec 31, 2024 | -383.59 Mn |
| Dec 31, 2024 | -383.59 Mn |
| Sep 30, 2024 | -9.59 Mn |
| Sep 30, 2024 | -9.59 Mn |
| Jun 30, 2024 | -841,000.00 |
| Jun 30, 2024 | -841,000.00 |
| Mar 31, 2024 | -533,000.00 |
| Mar 31, 2024 | -533,000.00 |
| Dec 31, 2023 | -1.48 Mn |
| Dec 31, 2023 | -1.48 Mn |
| Sep 30, 2023 | -1.50 Mn |
| Sep 30, 2023 | -1.50 Mn |
| Jun 30, 2023 | -4.39 Mn |
| Jun 30, 2023 | -4.39 Mn |
| Mar 31, 2023 | -3.62 Mn |
| Mar 31, 2023 | -3.62 Mn |
| Dec 31, 2022 | -633,000.00 |
| Dec 31, 2022 | -633,000.00 |
| Sep 30, 2022 | -6.80 Mn |
| Sep 30, 2022 | -6.80 Mn |
| Jun 30, 2022 | -2.64 Mn |
| Jun 30, 2022 | -2.64 Mn |
| Mar 31, 2022 | -771,000.00 |
| Mar 31, 2022 | -771,000.00 |
| Dec 31, 2021 | -1.59 Mn |
| Dec 31, 2021 | -1.59 Mn |
| Sep 30, 2021 | -3.86 Mn |
| Sep 30, 2021 | -3.86 Mn |
| Jun 30, 2021 | -1.51 Mn |
| Jun 30, 2021 | -1.51 Mn |
| Mar 31, 2021 | -1.90 Mn |
| Mar 31, 2021 | -1.90 Mn |
| Dec 31, 2020 | -5.47 Mn |
| Dec 31, 2020 | -5.47 Mn |
| Sep 30, 2020 | -4.05 Mn |
| Sep 30, 2020 | -4.05 Mn |
| Jun 30, 2020 | -2.52 Mn |
| Jun 30, 2020 | -2.52 Mn |
| Mar 31, 2020 | -2.64 Mn |
| Mar 31, 2020 | -2.64 Mn |
| Jun 30, 2019 | -12.97 Mn |
| Jun 30, 2019 | -12.97 Mn |
| Mar 31, 2019 | -7.33 Mn |
| Mar 31, 2019 | -7.33 Mn |
| Sep 30, 2018 | -9.53 Mn |
| Sep 30, 2018 | -9.53 Mn |
| Jun 30, 2018 | -5.47 Mn |
| Jun 30, 2018 | -5.47 Mn |
| Mar 31, 2018 | -4.96 Mn |
| Mar 31, 2018 | -4.96 Mn |
| Dec 31, 2017 | -764,000.00 |
| Dec 31, 2017 | -764,000.00 |